Table 3 Prevalence of BK polyomavirus (BKPyV) according to socio-demographic data and tumor characteristics among patients with bladder cancer in the South of Iran
No. of all participants (%): 181 (100%) | No. of BKPyV positive subjects (%): 3 (1.7%) | No. of BKPyV negative subjects (%):178 (98.3%) | P-Value | |
|---|---|---|---|---|
Age groups (years) | 0.374 | |||
27–39 | 7 (3.9) | 0 (0.0) | 7 (3.9) | |
40–49 | 15 (8.3) | 0 (0.0) | 15 (8.4) | |
50–59 | 46 (25.4) | 0 (0.0) | 46 (25.8) | |
60–69 | 45 (24.9) | 0 (0.0) | 45 (25.3) | |
70–79 | 39 (21.5) | 2 (66.7) | 37 (20.8) | |
≥ 80 | 29 (16.0) | 1 (33.3) | 28 (15.7) | |
Gender | 0.330 | |||
Male | 138 (76.2) | 3 (100.0) | 135 (75.8) | |
Female | 43 (23.8) | 0 (0.0) | 43 (24.2) | |
Place of residence (city) | 0.387 | |||
Bushehr | 63 (34.8) | 0 (0.0) | 63 (35.4) | |
Tangestan | 27 (14.9) | 2 (66.7) | 25 (14.0) | |
Dashtestan | 38 (21.0) | 0 (0.0) | 38 (21.3) | |
Dashti | 25 (13.8) | 1 (33.3) | 24 (13.5) | |
Dayer | 11 (6.1) | 0 (0.0) | 11 (6.2) | |
Deylam | 3 (1.7) | 0 (0.0) | 3 (1.7) | |
Kangan | 5 (2.8) | 0 (0.0) | 5 (2.8) | |
Genaveh | 8 (4.4) | 0 (0.0) | 8 (4.5) | |
Jam | 1 (0.6) | 0 (0.0) | 1 (0.6) | |
Stage of tumor | 0.600 | |||
Ta–T1 | 166 (91.7) | 3 (100.0) | 163 (91.6) | |
T2–T3 | 15 (8.3) | 0 (0.0) | 15 (8.4) | |
Grade of tumor | 0.986 | |||
Urothelial papilloma | 4 (2.2) | 0 (0.0) | 4 (2.2) | |
Papillary urothelial neoplasms of low malignant | 62 (34.3) | 1 (33.3) | 61 (34.3) | |
Low-grade papillary urothelial carcinoma | 68 (37.6) | 1 (33.3) | 67 (37.6) | |
High-grade papillary urothelial carcinoma | 47 (26.0) | 1 (33.3) | 46 (25.8) |